![Errol Arkilic](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Errol Arkilic
Directeur Général chez
M34 Capital, Inc.
Profil
Errol Arkilic is the founder of Elah Holdings, Inc. (founded in 2013), Stratagent Life Sciences, Inc. (founded in 2001), and M34 Capital, Inc. (founded in 2014).
He held the title of Chief Executive Officer at Stratagent Life Sciences, Inc. from 2001 to 2003.
Currently, Dr. Arkilic is a Member of the Board of Directors at Growcentia, Inc. (since 2015), Neurotrainer, Inc. (since 2018), and a Venture Partner at NextGen Venture Partners LLC.
He previously worked as a Director at Smartphage, Inc. Dr. Arkilic completed his undergraduate degree at George Washington University in 1991 and obtained a doctorate degree from Massachusetts Institute of Technology in 1997.
Postes actifs de Errol Arkilic
| Sociétés | Poste | Début |
|---|---|---|
M34 Capital, Inc.
 M34 Capital, Inc. Investment ManagersFinance M34 Capital invests in companies located in the United States. The firm targets companies operating in the fields of the technology services. It provides financing for seed stage capital requirements with an investment size of USD 0.25 - 0.50 million. | Directeur Général | 01/01/2014 |
Neurotrainer, Inc.
 Neurotrainer, Inc. Information Technology ServicesTechnology Services Provides virtual reality measurement and training services for athletic | Directeur/Membre du Conseil | 01/06/2018 |
Growcentia, Inc.
 Growcentia, Inc. Chemicals: AgriculturalProcess Industries Manufactures plant biogrowth stimulants | Directeur/Membre du Conseil | 01/03/2015 |
NextGen Venture Partners LLC
 NextGen Venture Partners LLC Investment ManagersFinance NextGen Venture Partners invests in companies located in the United States with a minimum revenues of USD 10 million. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 0.5 - 2 million for seed and early stage companies and USD 3 - 5 million for growth stage companies. | Private Equity Investor | - |
Anciens postes connus de Errol Arkilic
| Sociétés | Poste | Fin |
|---|---|---|
Stratagent Life Sciences, Inc.
 Stratagent Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops non-invasive drug therapies | Directeur Général | 01/01/2003 |
| ELAH HOLDINGS, INC. | Fondateur | - |
Smartphage, Inc.
 Smartphage, Inc. Internet Software/ServicesTechnology Services Provides an automated platform for the development of custom phage products | Directeur/Membre du Conseil | - |
Formation de Errol Arkilic
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
94
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Stratagent Life Sciences, Inc.
Stratagent Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops non-invasive drug therapies | Health Technology |
George Washington University
 George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Elah Holdings, Inc.
 Elah Holdings, Inc. Financial ConglomeratesFinance Functions as a holding company with interest focused on acquiring profitable commercial and industrial businesses | Finance |
NextGen Venture Partners LLC
NextGen Venture Partners LLC Investment ManagersFinance NextGen Venture Partners invests in companies located in the United States with a minimum revenues of USD 10 million. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 0.5 - 2 million for seed and early stage companies and USD 3 - 5 million for growth stage companies. | Finance |
M34 Capital, Inc.
M34 Capital, Inc. Investment ManagersFinance M34 Capital invests in companies located in the United States. The firm targets companies operating in the fields of the technology services. It provides financing for seed stage capital requirements with an investment size of USD 0.25 - 0.50 million. | Finance |
Smartphage, Inc.
Smartphage, Inc. Internet Software/ServicesTechnology Services Provides an automated platform for the development of custom phage products | Technology Services |
Growcentia, Inc.
Growcentia, Inc. Chemicals: AgriculturalProcess Industries Manufactures plant biogrowth stimulants | Process Industries |
Neurotrainer, Inc.
Neurotrainer, Inc. Information Technology ServicesTechnology Services Provides virtual reality measurement and training services for athletic | Technology Services |
